GSK729
GSK729 is a THPP inhibitor with the activity of inhibiting EchA6 and inhibiting Mycobacterium tuberculosis. GSK729 can selectively pull down EchA6 in a stereospecific manner, inhibit its activity, inhibit fatty acid synthesis of Mycobacterium tuberculosis, and has a bactericidal effect in a mouse chronic tuberculosis infection model.
Product Specifications
CAS Number
[1403602-92-5]
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/gsk729.html
Smiles
O=C(O)C1=C2N[C@H](C[C@H](N2N=C1)C(F)(F)F)C3=CC=C(C=C3)CC
Molecular Formula
C16H16F3N3O2
Molecular Weight
339.31
References & Citations
[1]THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
APC/CY7-Linked Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
APC/CY7-Linked Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
APC/CY7-Linked Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
APC/CY7-Linked Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
APC/CY7-Linked Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)